c/o Brookwood Pharmaceuticals Inc.
756 Tom Martin Drive
In Vivo briefly summarizes the technologies of these recently founded companies: Aeon Bioscience, Airmid, Centrose, Indigo Pharmaceuticals, Medella Therapeutics, and Xcovery.
c/o Brookwood Pharmaceuticals Inc.
756 Tom Martin Drive
Bristol Myers Squibb executive Doxie Jordan discusses his path to global commercial leadership and the principles guiding pharmaceutical market strategy
Devika Wood, CEO of Brain+, explains the importance of developing health tech solutions for dementia and the growing need to both raise awareness and improve overall access to nondrug interventions like CST.
In a challenging funding environment for biopharma, strategic dealmaking has become a critical growth engine. In Vivo explores what it truly takes to navigate high-stakes acquisitions and partnerships, drawing on insights from seasoned industry leaders.